Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma

Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma

Background: Omalizumab is effective and well-tolerated in children with moderate to severe allergic asthma. However, the effects of long-term treatment with omalizumab in this population haven't been well investigated. The objective of this study is to evaluate the long-term safety, efficacy, p...

Full description

Bibliographic Details
Main Authors: Hiroshi Odajima, Motohiro Ebisawa, Toshikazu Nagakura, Takao Fujisawa, Akira Akasawa, Komei Ito, Satoru Doi, Koichi Yamaguchi, Toshio Katsunuma, Kazuyuki Kurihara, Takahide Teramoto, Kazuko Sugai, Mitsuhiko Nambu, Akira Hoshioka, Shigemi Yoshihara, Norio Sato, Noriko Seko, Sankei Nishima
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Allergology International
Subjects:
Childhood asthma
Efficacy
Omalizumab
Safety evaluation
Total IgE
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893016300880

Internet

http://www.sciencedirect.com/science/article/pii/S1323893016300880

Similar Items